WHI-P258
CAS No. 21561-09-1
WHI-P258( WHI-P258 | WHI-P 258 | WHI-P-258 | WHIP 258 )
Catalog No. M13440 CAS No. 21561-09-1
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 46 | In Stock |
|
| 10MG | 72 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 224 | In Stock |
|
| 100MG | 377 | In Stock |
|
| 500MG | 861 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWHI-P258
-
NoteResearch use only, not for human use.
-
Brief DescriptionWHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
-
DescriptionWHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK binding negative control in the development of new therapeutics.
-
In Vitro——
-
In Vivo——
-
SynonymsWHI-P258 | WHI-P 258 | WHI-P-258 | WHIP 258
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR| JAK3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number21561-09-1
-
Formula Weight281.31
-
Molecular FormulaC16H15N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: <1.2mg/mL
-
SMILESCOC1=CC2=NC=NC(NC3=CC=CC=C3)=C2C=C1OC
-
Chemical Name6,7-Dimethoxy-N-phenylquinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.
molnova catalog
related products
-
VUF 10166
VUF10166 is a novel, potent and competitive antagonist for 5-HT3A receptor with Ki of 0.04 nM, its affinity at 5-HT3AB receptor is significantly lower.
-
EGFR-IN-7
EGFR-IN-7 is a selective and potent EGFR kinase inhibitor.TQB3804 displayed potent enzymatic activities for EGFRd746-750/T790M/C797S, EGFRL858R/T790M/C797S, EGFRd746-750/T790M, and EGFRL858R/T790M with IC50 of 0.46, 0.13, 0.26, and 0.19 nM respectively, and has similar enzymatic activity for EGFRWT (IC50 = 1.07) to Osimertinib.
-
CHF5074
CHF5074, a γ-secretase modulator, reduces Aβ42/40 secretion (IC50: 3.6/18.4 μM).
Cart
sales@molnova.com